Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 12/20 | 0.77 |
| ▸ | CNR1 | P21554 | 10/20 | 0.77 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.50 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.50 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.50 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29353562 | 1.00 | CNR2 (0.77) | CNR2CNR1OPRM1TRPV1TRPA1 | |
| SCHEMBL22916046 | 1.00 | CNR2 (0.77) | CNR2CNR1OPRM1TRPV1TRPA1 | |
| SCHEMBL13214138 | 1.00 | CNR2 (0.77) | CNR2CNR1OPRM1TRPV1TRPA1 | |
| SCHEMBL13214146 | 1.00 | CNR2 (0.77) | CNR2CNR1OPRM1TRPV1TRPA1 | |
| SCHEMBL13214147 | 1.00 | CNR2 (0.77) | CNR2CNR1OPRM1TRPV1TRPA1 | |
| SCHEMBL16124350 | 0.97 | CNR2 (0.72) | CNR2CNR1OPRM1TRPV1TRPA1 | |
| SCHEMBL13214144 | 0.93 | CNR2 (0.66) | CNR2CNR1OPRM1TRPV1TRPA1 | |
| SCHEMBL23076632 | 0.86 | CNR2 (0.66) | CNR2CNR1OPRM1TRPV1TRPA1 | |
| SCHEMBL29400773 | 0.86 | CNR2 (0.66) | CNR2CNR1OPRM1TRPV1TRPA1 | |
| SCHEMBL13214145 | 0.86 | CNR2 (0.66) | CNR2CNR1OPRM1TRPV1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199505-A1 | SOIL AMENDMENT FOR SOLUBILIZING SILICATE IN SOIL | MORGANICS CORP. (CA) | 2024-06-20 | — | — | US | disclosed |
| US-11707444-B2 | Antiviral composition for SARS-CoV-2 containing cannabinoids as active ingredient | RESEARCH COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY (KR) | 2023-07-25 | — | — | US | disclosed |
| US-11707444-B2 | Antiviral composition for SARS-CoV-2 containing cannabinoids as active ingredient | RESEARCH COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY (KR) | 2023-07-25 | — | — | US | disclosed |
| US-20230002340-A1 | SEPARATION OF CANNABINOIDS FROM MIXTURES THEREOF BY DISTILLATION | CANOPY GROWTH CORPORATION (CA) | 2023-01-05 | — | — | US | disclosed |
| US-20220332693-A1 | SEPARATION OF CANNABINOIDS FROM MIXTURES THEREOF BY EXTRACTION AND DISTILLATION | CANOPY GROWTH CORPORATION (CA) | 2022-10-20 | — | — | US | disclosed |
| US-20220289703-A1 | METHODS FOR CONVERTING TETRAHYDROCANNABINOLIC ACID INTO CANNABINOLIC ACID | CANOPY GROWTH CORPORATION (CA) | 2022-09-15 | — | — | US | disclosed |
| US-20220218653-A1 | CARTRIDGE FOR VAPOR-PHASE CANNABINOID REACTIONS WITHIN A DEVICE | CANOPY GROWTH CORPORATION (CA) | 2022-07-14 | — | — | US | disclosed |
| US-20220202710-A1 | WATER-SOLUBLE FORMULATIONS, METHODS OF MAKING AND USE | CANOPY GROWTH CORPORATION (CA) | 2022-06-30 | — | — | US | disclosed |
| US-20220177442-A1 | METHODS FOR CONVERTING THC-RICH CANNABINOID MIXTURES INTO CBN-RICH CANNABINOID MIXTURES | JGB COLLATERAL LLC | 2022-06-09 | — | — | US | disclosed |
| WO-2021127788-A1 | METHODS OF SYNTHESIZING HIGH-PURITY CANNABICYCLOL AND ARTIFICIAL RESINS COMPRISING CANNABICYCLOL | CANOPY GROWTH CORPORATION (CA) | 2021-07-01 | — | — | WO | disclosed |
| WO-2021016716-A1 | SEPARATION OF CANNABINOIDS FROM CANNABINOID MIXTURES BY DERIVATIZATION | CANOPY GROWTH CORPORATION (CA) | 2021-02-04 | — | — | WO | disclosed |
| WO-2021016717-A1 | SEPARATION OF CANNABINOIDS FROM MIXTURES THEREOF BY EXTRACTION AND DISTILLATION | CANOPY GROWTH CORPORATION (CA) | 2021-02-04 | — | — | WO | disclosed |
| WO-2020248056-A1 | CARTRIDGE FOR VAPOR-PHASE CANNABINOID REACTIONS WITHIN A DEVICE | CANOPY GROWTH CORPORATION (CA) | 2020-12-17 | — | — | WO | disclosed |
| WO-2020248062-A1 | IMPROVED METHODS FOR CANNABINOID ISOMERIZATION | CANOPY GROWTH CORPORATION (CA) | 2020-12-17 | — | — | WO | disclosed |
| WO-2020248059-A1 | METHODS FOR PREPARING CANNABINOIDS BY BASE-PROMOTED DOUBLE-BOND MIGRATION | CANOPY GROWTH CORPORATION (CA) | 2020-12-17 | — | — | WO | disclosed |
| WO-2020248057-A1 | METHODS FOR PREPARING CANNABINOIDS BY HETEROGENEOUS-ACID-PROMOTED DOUBLE-BOND MIGRATION | CANOPY GROWTH CORPORATION (CA) | 2020-12-17 | — | — | WO | disclosed |
| WO-2020107119-A1 | COMPOSITIONS COMPRISING A CANNABINOID OR A CANNABIS-DERIVED COMPOUND, METHODS OF MAKING AND USE | CANOPY GROWTH CORPORATION (CA) | 2020-06-04 | — | — | WO | disclosed |
| WO-2020107114-A1 | WATER-SOLUBLE FORMULATIONS OF CANNABINOIDS OR CANNABIS-DERIVED COMPOUNDS, METHODS OF MAKING AND USE | CANOPY GROWTH CORPORATION (CA) | 2020-06-04 | — | — | WO | disclosed |
| US-20200170950-A1 | COMPOSITIONS COMPRISING A CANNABINOID OR A CANNABIS-DERIVED COMPOUND, METHODS OF MAKING AND USE | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2020-06-04 | — | — | US | disclosed |
| WO-2019071302-A1 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING SEIZURES | THE UNIVERSITY OF SYDNEY (AU) | 2019-04-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002340-A1 | SEPARATION OF CANNABINOIDS FROM MIXTURES THEREOF BY DISTILLATION | CNR2, CNR1, PLEC | CNR2 1/4885CNR1 2/4885OPRM1 244/4885 |
| US-20220177442-A1 | METHODS FOR CONVERTING THC-RICH CANNABINOID MIXTURES INTO CBN-RICH CANNABINOID MIXTURES | CNR1, CNR2, FAAH | CNR2 2/4885CNR1 1/4885OPRM1 152/4885 |
| US-20220202710-A1 | WATER-SOLUBLE FORMULATIONS, METHODS OF MAKING AND USE | CNR1, CNR2, FAAH | CNR2 2/4885CNR1 1/4885OPRM1 104/4885 |
| US-20220289703-A1 | METHODS FOR CONVERTING TETRAHYDROCANNABINOLIC ACID INTO CANNABINOLIC ACID | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885OPRM1 687/4885 |
| US-20200170950-A1 | COMPOSITIONS COMPRISING A CANNABINOID OR A CANNABIS-DERIVED COMPOUND, METHODS OF MAKING AND USE | CNR1, CNR2, CSGALNACT1 | CNR2 2/4885CNR1 1/4885OPRM1 16/4885 |
| US-20220218653-A1 | CARTRIDGE FOR VAPOR-PHASE CANNABINOID REACTIONS WITHIN A DEVICE | CNR1, CNR2, FAAH | CNR2 2/4885CNR1 1/4885OPRM1 77/4885 |
| US-20220332693-A1 | SEPARATION OF CANNABINOIDS FROM MIXTURES THEREOF BY EXTRACTION AND DISTILLATION | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885OPRM1 79/4885 |
| US-11707444-B2 | Antiviral composition for SARS-CoV-2 containing cannabinoids as active ingredient | TMPRSS2, ACE2, CNR2 | CNR2 3/4885CNR1 4/4885OPRM1 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.